Drug Shortage Report for LEVITRA
Report ID | 113348 |
Drug Identification Number | 02250489 |
Brand name | LEVITRA |
Common or Proper name | VARDENAFIL |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | VARDENAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4's |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-06-15 |
Actual start date | 2020-06-05 |
Estimated end date | |
Actual end date | 2020-10-16 |
Shortage status | Resolved |
Updated date | 2020-10-19 |
Company comments | Product is available to market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-10-19 | French | Compare |
v8 | 2020-10-19 | English | Compare |
v7 | 2020-06-08 | French | Compare |
v6 | 2020-06-08 | English | Compare |
v5 | 2020-06-08 | English | Compare |
v4 | 2020-06-04 | French | Compare |
v3 | 2020-06-04 | English | Compare |
v2 | 2020-04-28 | French | Compare |
v1 | 2020-04-28 | English | Compare |
Showing 1 to 9 of 9